Allegion (NYSE:ALLE) PT Lowered to $113.00 at The Goldman Sachs Group

Allegion (NYSE:ALLEGet Rating) had its target price lowered by equities research analysts at The Goldman Sachs Group from $140.00 to $113.00 in a research report issued on Thursday, Stock Target Advisor reports. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. The Goldman Sachs Group’s price target indicates a potential upside of 18.56% from the stock’s previous close.

ALLE has been the topic of several other reports. Robert W. Baird cut their price target on shares of Allegion from $140.00 to $135.00 in a research report on Wednesday, April 20th. William Blair restated a “market perform” rating on shares of Allegion in a research note on Tuesday, April 26th. StockNews.com started coverage on shares of Allegion in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Morgan Stanley lowered their price objective on shares of Allegion from $120.00 to $115.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 31st. Finally, Barclays lowered their price objective on shares of Allegion from $160.00 to $150.00 and set an “overweight” rating on the stock in a research note on Monday, April 4th. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Allegion has an average rating of “Hold” and a consensus price target of $137.33.

ALLE traded down $0.14 during trading on Thursday, hitting $95.31. The company had a trading volume of 1,789 shares, compared to its average volume of 736,963. The company has a market capitalization of $8.37 billion, a PE ratio of 18.29, a PEG ratio of 1.88 and a beta of 1.03. Allegion has a one year low of $93.05 and a one year high of $148.70. The firm’s 50-day moving average price is $109.59 and its 200 day moving average price is $116.41. The company has a quick ratio of 1.16, a current ratio of 1.85 and a debt-to-equity ratio of 1.92.

Allegion (NYSE:ALLEGet Rating) last posted its quarterly earnings data on Tuesday, April 26th. The scientific and technical instruments company reported $1.07 EPS for the quarter, beating the consensus estimate of $0.99 by $0.08. Allegion had a net margin of 16.15% and a return on equity of 57.54%. The business had revenue of $723.60 million for the quarter, compared to analysts’ expectations of $709.67 million. During the same period in the previous year, the firm posted $1.20 EPS. The firm’s revenue was up 4.2% compared to the same quarter last year. Sell-side analysts forecast that Allegion will post 5.63 earnings per share for the current year.

In other news, SVP Tracy L. Kemp sold 2,544 shares of the company’s stock in a transaction that occurred on Monday, May 9th. The shares were sold at an average price of $112.55, for a total transaction of $286,327.20. Following the completion of the sale, the senior vice president now owns 10,379 shares of the company’s stock, valued at approximately $1,168,156.45. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Robert C. Martens sold 2,150 shares of the company’s stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $112.07, for a total transaction of $240,950.50. Following the sale, the senior vice president now directly owns 5,433 shares of the company’s stock, valued at approximately $608,876.31. The disclosure for this sale can be found here. Insiders sold a total of 8,926 shares of company stock valued at $1,004,286 in the last three months. Insiders own 0.79% of the company’s stock.

Several institutional investors have recently modified their holdings of ALLE. LPL Financial LLC lifted its stake in Allegion by 17.3% in the 3rd quarter. LPL Financial LLC now owns 19,665 shares of the scientific and technical instruments company’s stock valued at $2,599,000 after purchasing an additional 2,903 shares during the last quarter. UBS Group AG lifted its stake in Allegion by 27.0% in the 3rd quarter. UBS Group AG now owns 96,151 shares of the scientific and technical instruments company’s stock valued at $12,709,000 after purchasing an additional 20,462 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in Allegion by 29.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 22,042 shares of the scientific and technical instruments company’s stock valued at $2,950,000 after purchasing an additional 4,962 shares during the last quarter. Captrust Financial Advisors increased its position in Allegion by 29.2% in the 3rd quarter. Captrust Financial Advisors now owns 2,398 shares of the scientific and technical instruments company’s stock valued at $317,000 after acquiring an additional 542 shares during the period. Finally, Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Allegion in the 3rd quarter valued at approximately $317,000. 95.21% of the stock is owned by institutional investors.

Allegion Company Profile (Get Rating)

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories.

Read More

Stock Target Advisor logo

Analyst Recommendations for Allegion (NYSE:ALLE)

Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.